<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:department>Warwick Medical School</gtr:department><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/78C7CFF7-1B93-451B-84BF-80069C773102"><gtr:id>78C7CFF7-1B93-451B-84BF-80069C773102</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Royle</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH015582%2F2"><gtr:id>AE2418CC-1DCF-419F-B055-115F52F1EBBF</gtr:id><gtr:title>Moonlighting functions of endocytic proteins during the cell cycle</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H015582/2</gtr:grantReference><gtr:abstractText>Cells can be thought of as islands - they are closed to the outside world because they have a plasma membrane that doesn't let anything through. However, cells have evolved tiny portals for things to enter in a tightly regulated way. These portals are working all the time, but they are shut down when the cell needs to divide. It is important that no mistakes are made at this time. Otherwise the cell could die or it could start to grow in an unusual way leading to disease e.g. cancer. Nobody knows how this shutdown happens. We want to study the portals using a machine that can tell us all the pieces that make up a portal. If we compare portals from normal cells with those that are dividing this will tell us which pieces are missing in dividing cells. We can then find out how the cell takes these pieces away at the start of cell division. We think that this work is important to do. These portals are hijacked by viruses: they use portals as a way to infect cells. If we knew how the cell shuts down the portals, we could think of ways to switch them off using drugs. These drugs could be used as anti-viral treatments.</gtr:abstractText><gtr:technicalSummary>Clathrin-coated vesicles (CCVs) are formed continuously in non-dividing cells. When the cell enters mitosis, membrane trafficking is shut down. This phenomenon has been acknowledged for almost fifty years, but the mechanism behind the shutdown has been enigmatic. It is thought that certain components of the clathrin coat are phosphorylated during mitosis and this prevents their engagement with the network of proteins responsible for driving CCV formation. In addition, there is an emerging concept in cell biology of proteins with alternative functions during mitosis. In this project, we will investigate the link between those proteins that are missing from coats in mitotic cells, those that are phosphorylated and those that carry out alternative functions. We propose a systematic and quantitative proteomic study of clathrin-coated membranes from cells in interphase and in mitosis. This will allow us to identify the proteins that are less abundant in clathrin coats from mitotic cells. Using live-cell imaging, we will determine at what stage in the cell cycle these proteins cease to be recruited to the coat and also investigate where in the cell the protein is localised during this time. Finally, we will discover whether these proteins are phosphorylated and whether or not this modification is responsible for the mitotic shutdown of CCV formation.</gtr:technicalSummary><gtr:potentialImpactText>The major stakeholders impacted by this research are: 1. International scientific community: cell biologists and biochemists 2. Local scientific community: systems biology research in Liverpool 3. Commercial sector Our strategy for engaging with these stakeholders is outlined in the Impact Plan.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-07-22</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>74156</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Open Access from a PI's perspective, Crick Institute Retreat</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DC42151C-F9E1-48D9-8BB9-593718E4BD3F</gtr:id><gtr:impact>EuropePMC and I presented on how to make your research outputs freely accessible and how to disseminate outcomes widely

Lots of discussion followed the event at the reception and via email and twitter afterwards</gtr:impact><gtr:outcomeId>542d64eea4e684.45309828</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Access from a Researcher's perspective, EuropePMC funder's Group, British Library</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0E2DFB18-0006-4E57-9D50-D98266852410</gtr:id><gtr:impact>Around 30 representatives from groups that fund EuropePMC assembled for the day to listen to developments at the repository. I talked about Open Access from a researcher's perspective.

Lively discussion with participants. Involvement in future events and studies on research outcome sharing.</gtr:impact><gtr:outcomeId>542d645bbc8ad8.59344403</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1490400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Alert14 (50% University of Warwick)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M01228X/1</gtr:fundingRef><gtr:id>13A72731-1B92-435C-8034-588552BA8893</gtr:id><gtr:outcomeId>5458991556c879.46597221</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our work has been well received in the academic sector. Papers arising from this award have been well-cited.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>D5045FF8-F1BA-4C9F-8EC3-96A34CC1F3C0</gtr:id><gtr:impactTypes/><gtr:outcomeId>542d5993d95cd6.47603544</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>All the time, cells take up chunks of plasma membrane and recycle them. They use this recycling system to control many aspects of cell function: signalling, degradation, nutrient uptake etc. When cells begin to divide they switch off the uptake process. This had been known for half a century, but nobody knew how this happened. We have discovered the mechanism that cells use to inhibit this activity during cell division.</gtr:description><gtr:exploitationPathways>Cells that are rapidly dividing, e.g. in cancer are less likely to take up drugs that enter via this pathway. The mechanism we have discovered is an opportunity to restart the uptake pathway to help drug delivery to rapidly dividing cells.</gtr:exploitationPathways><gtr:id>BD4FEE97-FA13-4105-A902-1FFADB2FEE64</gtr:id><gtr:outcomeId>542d5af03798f6.37927792</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A7297020-FC97-473B-AF4D-C6B24FDDBEE5</gtr:id><gtr:title>An unmet actin requirement explains the mitotic inhibition of clathrin-mediated endocytosis.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a53e5c880b1c6ad2c305e198d2444be"><gtr:id>1a53e5c880b1c6ad2c305e198d2444be</gtr:id><gtr:otherNames>Kaur S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>542d5e38817027.47781701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDB5F992-B19A-4FA9-A42F-2C94E5D31F2C</gtr:id><gtr:title>Mitotic inhibition of clathrin-mediated endocytosis.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/151730a8893190c1cdaee7a90644995b"><gtr:id>151730a8893190c1cdaee7a90644995b</gtr:id><gtr:otherNames>Fielding AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>542d5e39b27085.43842758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6DBBCE8-0F40-4C85-97E8-98948E055F5F</gtr:id><gtr:title>Clathrin-mediated endocytosis is inhibited during mitosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/151730a8893190c1cdaee7a90644995b"><gtr:id>151730a8893190c1cdaee7a90644995b</gtr:id><gtr:otherNames>Fielding AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>542d5e3a2c1f91.03404600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C694635-EDDC-4B9A-94E2-4CDCBF784D65</gtr:id><gtr:title>Presynaptic clathrin levels are a limiting factor for synaptic transmission.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed04837944770e3e0398c4982a4b9cb"><gtr:id>aed04837944770e3e0398c4982a4b9cb</gtr:id><gtr:otherNames>L?pez-Murcia FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>542d5e382161a0.70790464</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H015582/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>3DC1ADAD-B5A6-48D8-B54B-849B69E73A24</gtr:id><gtr:grantRef>BB/H015582/1</gtr:grantRef><gtr:amount>187132.11</gtr:amount><gtr:start>2010-12-01</gtr:start><gtr:end>2013-01-31</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>AE2418CC-1DCF-419F-B055-115F52F1EBBF</gtr:id><gtr:grantRef>BB/H015582/2</gtr:grantRef><gtr:amount>74156.03</gtr:amount><gtr:start>2013-07-22</gtr:start><gtr:end>2014-08-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>